Variant report
Variant | esv3379880 |
---|---|
Chromosome Location | chr8:131908231-131911290 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:12)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:12 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | E2F4 | chr8:131910598-131910606 | MCF10A-Er-Src | breast: | n/a | n/a |
2 | EP300 | chr8:131906997-131908281 | SK-N-SH | brain: | n/a | chr8:131907668-131907682 |
3 | GATA3 | chr8:131907156-131908350 | SK-N-SH | brain: | n/a | chr8:131907986-131907996 chr8:131907651-131907664 chr8:131907559-131907568 chr8:131907989-131907996 chr8:131907989-131907996 chr8:131907989-131907996 |
4 | GATA3 | chr8:131907025-131908660 | SK-N-SH | brain: | n/a | chr8:131907986-131907996 chr8:131907651-131907664 chr8:131907559-131907568 chr8:131907989-131907996 chr8:131907989-131907996 chr8:131907989-131907996 |
5 | GATA3 | chr8:131908516-131908651 | SH-SY5Y | brain: | n/a | n/a |
6 | MYC | chr8:131908663-131908747 | MCF10A-Er-Src | breast: | n/a | n/a |
7 | NFIC | chr8:131907376-131908255 | SK-N-SH | brain: | n/a | n/a |
8 | PBX3 | chr8:131907134-131908302 | SK-N-SH | brain: | n/a | n/a |
9 | POLR2A | chr8:131910317-131910477 | MCF10A-Er-Src | breast: | n/a | n/a |
10 | STAT3 | chr8:131910956-131911000 | MCF10A-Er-Src | breast: | n/a | n/a |
11 | TCF12 | chr8:131907323-131908249 | SK-N-SH | brain: | n/a | n/a |
12 | TCF12 | chr8:131907010-131908314 | SK-N-SH | brain: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000253259 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs553902894 | chr8:131908279-131908280 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs10956560 | chr8:131908293-131908294 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs117700278 | chr8:131908357-131908358 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs191652584 | chr8:131908488-131908489 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs74485277 | chr8:131908498-131908499 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs543616159 | chr8:131908502-131908503 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs74540670 | chr8:131908503-131908504 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs574272947 | chr8:131908509-131908510 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs150034757 | chr8:131908562-131908563 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs184604036 | chr8:131908580-131908581 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs10956561 | chr8:131908662-131908663 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs544774137 | chr8:131908664-131908665 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs563376390 | chr8:131908665-131908666 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs11779492 | chr8:131908694-131908695 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs145295270 | chr8:131908714-131908715 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs567541468 | chr8:131908728-131908729 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs73346438 | chr8:131908735-131908736 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs563416918 | chr8:131908738-131908739 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs34660831 | chr8:131908767-131908768 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs11786442 | chr8:131908770-131908771 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs149193665 | chr8:131908783-131908784 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs142306628 | chr8:131908836-131908837 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs372776411 | chr8:131908839-131908840 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs11777051 | chr8:131908877-131908878 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs537218829 | chr8:131909052-131909053 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs79762305 | chr8:131909083-131909084 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs574210182 | chr8:131909173-131909174 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs73346442 | chr8:131909177-131909178 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs12550604 | chr8:131909208-131909209 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs577520024 | chr8:131909245-131909246 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs545032878 | chr8:131909251-131909252 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs75593679 | chr8:131909271-131909272 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs542773998 | chr8:131909323-131909324 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs560913261 | chr8:131909398-131909399 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs528331274 | chr8:131909408-131909409 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs188969481 | chr8:131909412-131909413 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs146822658 | chr8:131909487-131909488 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs533160812 | chr8:131909529-131909530 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs551391449 | chr8:131909601-131909602 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs193069285 | chr8:131909612-131909613 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs75687443 | chr8:131909647-131909648 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs549075226 | chr8:131909666-131909667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs74685823 | chr8:131909687-131909688 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs185695165 | chr8:131909772-131909773 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs535268009 | chr8:131909773-131909774 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs553379965 | chr8:131909782-131909783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs190603509 | chr8:131909802-131909803 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs538614588 | chr8:131909815-131909816 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs556967320 | chr8:131909828-131909829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs370738314 | chr8:131909923-131909924 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastric cancer | 17908304 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Developmental delay | 21147756 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Papillary thyroid cancer | 17515504 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Gastric cancer | 21528007 | CNVD |
Breast cancer | 22532251 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21129771 | CNVD |
benign familial neonatal convulsions | 18472482 | CNVD |
Breast cancer | 16417655 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21183584 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Breast cancer | 20814816 | CNVD |
Colorectal cancer | 22486879 | CNVD |
Breast cancer | 17908964 | CNVD |
Colorectal cancer | 20031965 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Ovarian cancer | 17908964 | CNVD |
Ovarian cancer | 20031965 | CNVD |
Prostate cancer | 20031965 | CNVD |
Non-small cell lung cancer | 17643093 | CNVD |
Prostate cancer | 19242612 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Chordoma | 18071362 | CNVD |
Breast cancer | 17850661 | CNVD |
head and neck squamous cell carcinoma | 16740747 | CNVD |
Gastric cancer | 22539939 | CNVD |
Breast cancer | 16272173 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21611746 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Gastric cancer | 16891809 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Pregnancies with abnormal ultrasound findings | 21110858 | CNVD |
Breast cancer | 19181860 | CNVD |
Brain cancer | 19584924 | CNVD |
Medulloblastoma | 19584924 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Prostate cancer | 22341455 | CNVD |
Cancer | 20164919 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:131895800-131914600 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
2 | chr8:131907600-131908800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
3 | chr8:131911200-131911400 | Enhancers | HSMM | muscle |